This file is provided for reference purposes only. It was current when it was produced, but it is no longer maintained and may now be out of date. Persons with disabilities having difficulty accessing information may contact us
for assistance. For reliable, current information on this and other health topics, we recommend consulting the NIH Clinical Center at http://www.cc.nih.gov/
at the Millennium
Harvey G. Klein, M.D.
Chief, Department of Transfusion
Warren Grant Magnuson Clinical Center
The millennium brings exciting challenges
for blood transfusion. Human blood substitutes, inactivating blood-borne
infections, and using new blood components for gene therapy are
but a few.
Tonight, Dr. Harvey G. Klein, Chief of
the Clinical Centerís Department of Transfusion Medicine,
will explain more about these challengesóand opportunities.
He is a recognized leader in defining transfusion medicine as
a broad-based clinical and laboratory consultative subspecialty.
A native of Boston, Dr. Klein graduated
from Harvard College and earned his medical degree from The Johns
Hopkins School of Medicine. He did his internship and residency
at The Johns Hopkins University Hospital, where he was also a
Fellow in Hematology.
Dr. Klein came to NIH in 1973 as a member
of the Public Health Service Commissioned Officer Corps serving
the National Heart, Lung, and Blood Institute. He joined the Clinical
Center Blood Bank in 1975, holding various leadership positions
until he became its Chief in 1983.
Through his stewardship, the Blood Bank
evolved into the Department of Transfusion Medicine, the first
of its kind in the country.
Dr. Klein has published widely, authoring
or coauthoring more than 150 publications, including journal articles
and book chapters on transfusion medicine in major textbooks on
hematology, internal medicine, and blood banking. He is on the
editorial boards of Transfusion and Transfusion Medicine
He actively holds and has held leadership
positions in many professional organizations, including the American
Association of Blood Banks, the American Blood Commission, the
American Society of Hematology, and the Amer-ican Society for
Apheresis. Currently, he serves on the board of directors for
the Chesapeake and Potomac blood program of the American National
Red Cross and as Chairman of the Committee of Revision for Blood
and Blood Products for the U.S. Pharmacopeia.
Dr. Klein is a diplomate of the American
Board of Internal Medicine in the boardís hematology subspecialty,
and a diplomate of the American Board of Pathology, blood bank
He has been an invited speaker at national
and international symposia and has held named lectureships at
Yale University, Montefiore Medical Center, and Cedars-Sinai Medical
Center. This year, he is a Distinguished Visiting Professor of
Pathology at The Johns Hopkins School of Medicine.
Throughout his career, Dr. Klein has
received numerous awards, including a Meritorious Service Medal
from the Public Health Service, an NIH Clinical Center Directorís
Award, and most recently, the Cohn deLaval Medal from the World
For more information
about the Clinical Center and its Medicine for the Public lecture
series, contact CC Communications (OCCC@nih.gov),
of Health, Warren Grant Magnuson Clinical Center, Bethesda, Maryland
Series | CC home | NIH home
The information on this page is archived and provided for reference purposes only.